genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2021

Tuberous sclerosis

Jazz Pharma Expands Neuroscience Pipeline with $7.2B GW Acquisition
Drug Discovery

Jazz Pharma Expands Neuroscience Pipeline with $7.2B GW Acquisition

Alex Philippidis -
February 4, 2021
1
Transgenomic Alliance Aims to Advance Understanding of Genetic Disease Tuberous Sclerosis
News

Transgenomic Alliance Aims to Advance Understanding of Genetic Disease Tuberous Sclerosis

GEN Staff Writer -
November 19, 2014
0
Positive Trial Data Leads Novartis to Plan Breast Cancer Filing for Afinitor by Year End
Cancer

Positive Trial Data Leads Novartis to Plan Breast Cancer Filing for Afinitor by Year End

GEN Staff Writer -
July 5, 2011
0
Switzerland Clears Novartis’ Everolimus for Treating SEGA
Cancer

Switzerland Clears Novartis’ Everolimus for Treating SEGA

GEN Staff Writer -
May 11, 2011
0
Novartis’ Afinitor Cleared by FDA for Treating SEGA Tumors in Tuberous Sclerosis
News

Novartis’ Afinitor Cleared by FDA for Treating SEGA Tumors in Tuberous Sclerosis

GEN Staff Writer -
November 1, 2010
0

Recently Featured

<i>Candida auris</i> Needs This Protein to Colonize, Wreak Harm

Candida auris Needs This Protein to Colonize, Wreak Harm

Bone Loss Lessened by Blocking Abnormal Stem Cell Signal

Bone Loss Lessened by Blocking Abnormal Stem Cell Signal

Tuning Macrophages for Improved Tuberculosis Resistance

Tuning Macrophages for Improved Tuberculosis Resistance

p53 Found to Also Regulate Learning, Memory, and Sociability in Mice

p53 Found to Also Regulate Learning, Memory, and Sociability in Mice

Read the Digital Edition

August 2023 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Magazine Advertising
  • Website Banner Advertising
  • eNewsletter Advertising
  • Webinar Sponsorship
  • eBook Advertising
  • List Rental
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up